HMG
Sponsors
Ferring Pharmaceuticals, Zekai Tahir Burak Women's Health Research and Education Hospital, University of Turin, Italy, Hospital de Clinicas de Porto Alegre, IVI Madrid
Conditions
Female Infertility Due to Nonimplantation of OvumInfertilityInfertility Indicated for ICSIPolycystic Ovary Syndrome
Phase 3
Phase 4
hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF
CompletedNCT01365936
Start: 2008-01-31End: 2008-06-30Updated: 2012-03-29
Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist
CompletedNCT02412904
Start: 2014-01-31End: 2014-12-31Updated: 2015-08-21
Gonadotropin Type in Ovarian Stimulation
CompletedNCT02437032
Start: 2009-04-30End: 2012-12-31Updated: 2015-05-07
Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI
CompletedNCT02741154
Start: 2016-08-12End: 2017-09-03Updated: 2017-09-06
Unknown Phase
Assessment of the Effectiveness of Menopur in Intrauterine Insemination
CompletedNCT01354834
Start: 2004-03-31End: 2006-04-30Updated: 2025-03-28
Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization
CompletedNCT02322398
Start: 2010-03-31End: 2014-08-31Updated: 2014-12-23
Miniflare Versus Long Protocol in Poor Responders
NCT02681536
Start: 2016-02-29End: 2016-09-30Target: 200Updated: 2016-04-04
Letrozole and Sequential Clomiphene to Improve the Outcome of Embryo Transfer
NCT02775877
Start: 2016-05-31End: 2020-01-31Target: 100Updated: 2017-06-23